The Swiss bank believes the pharmaceutical giant's 30-drug-trial pipeline makes it a "leading player in this field" and expects shares to rise by nearly 30%.
from International: Top News And Analysis https://ift.tt/BTXO5v8
via IFTTT
Wednesday, July 12, 2023
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment